{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T17:57:40Z","timestamp":1759341460989,"version":"3.44.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":5931,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1016\/j.fertnstert.2005.08.040","type":"journal-article","created":{"date-parts":[[2006,2,22]],"date-time":"2006-02-22T07:25:10Z","timestamp":1140593110000},"page":"573-577","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Use of gonadotropin-releasing hormone antagonists to overcome the drawbacks of intrauterine insemination on weekends"],"prefix":"10.1016","volume":"85","author":[{"given":"Miguel A.","family":"Checa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Prat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Robles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ram\u00f3n","family":"Carreras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2005.08.040_bib1","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1093\/oxfordjournals.humrep.a138597","article-title":"Suppression of the endogenous luteinizing hormone surge by the gonadotrophin-releasing hormone antagonist Cetrorelix during ovarian stimulation","volume":"9","author":"Diedrich","year":"1994","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2005.08.040_bib2","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0015-0282(16)56933-7","article-title":"The single or dual administration of the gonadotropin-releasing hormone antagonist Cetrorelix in an in vitro fertilization\u2013embryo transfer program","volume":"62","author":"Olivennes","year":"1994","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2005.08.040_bib3","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1093\/humrep\/15.3.526","article-title":"Ovarian stimulation with HMG","volume":"15","author":"Albano","year":"2000","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2005.08.040_bib4","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1093\/humrep\/15.7.1490","article-title":"Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient","volume":"15","author":"Borm","year":"2000","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2005.08.040_bib5","doi-asserted-by":"crossref","unstructured":"The European and Middle East Orgalutran Study Group. Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation. Hum Reprod 200;16:644\u201351.","DOI":"10.1093\/humrep\/16.4.644"},{"key":"10.1016\/j.fertnstert.2005.08.040_bib6","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0015-0282(99)00524-5","article-title":"Prospective, randomized, controlled study of in vitro fertilization\u2013embryo transfer with a single dose of a luteinizing hormone-releasing hormone (LH-RH) antagonist (cetrorelix) or a depot formula of an LH-RH agonist (triptorelin)","volume":"73","author":"Olivennes","year":"2000","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2005.08.040_bib7","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0015-0282(97)81407-0","article-title":"Comparison of different doses of gonadotropin-releasing hormone antagonist Cetrorelix during controlled ovarian hyperstimulation","volume":"67","author":"Albano","year":"1997","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2005.08.040_bib8","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1093\/humrep\/13.11.3023","volume":"13","year":"1998","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2005.08.040_bib9","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1111\/j.1471-0528.2003.02290.x","article-title":"Ovulation induction with a starting dose of 50 IU of recombinant follicle stimulating hormone in WHO group II anovulatory women","volume":"110","author":"Calaf Alsina","year":"2003","journal-title":"BJOG"},{"key":"10.1016\/j.fertnstert.2005.08.040_bib10","series-title":"The Cochrane Library, Issue 4","article-title":"Gonadotrophin-releasing hormone antagonists for assisted conception (Cochrane Review)","author":"Al-Inany","year":"2004"},{"key":"10.1016\/j.fertnstert.2005.08.040_bib11","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1093\/humrep\/16.11.2258","article-title":"Comparison of luteal phase profile in gonadotrophin stimulated cycles with or without a gonadotrophin-releasing hormone antagonist","volume":"16","author":"Ragni","year":"2001","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2005.08.040_bib12","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00404-001-0267-2","article-title":"Use of GnRH antagonists in ovarian stimulation for assisted reproductive technologies compared to the long protocol. Meta-analysis","volume":"265","author":"Ludwig","year":"2001","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.fertnstert.2005.08.040_bib13","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1093\/humrep\/deg461","article-title":"The effect of endometrial thickness on IVF\/ICSI outcome","volume":"18","author":"Kovacs","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2005.08.040_bib14","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0015-0282(99)00316-7","article-title":"Risk factors for multiple gestation in women undergoing intrauterine insemination with ovarian stimulation","volume":"72","author":"Pasqualotto","year":"1999","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2005.08.040_bib15","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/humrep\/14.3.698","article-title":"Intrauterine insemination treatment in subfertility","volume":"14","author":"Nuojua-Huttunen","year":"1999","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2005.08.040_bib16","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1093\/oxfordjournals.humrep.a019513","article-title":"Prognostic indicators for intrauterine insemination (IUI)","volume":"11","author":"Tomlinson","year":"1996","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2005.08.040_bib17","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.bpobgyn.2004.05.006","article-title":"Management of infertility and prevention of ovarian hyperstimulation in women with polycystic ovary syndrome","volume":"18","author":"Homburg","year":"2004","journal-title":"Best Pract Res Clin Obstet Gynaecol"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028205039695?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028205039695?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T07:10:46Z","timestamp":1758006646000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028205039695"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["S0015028205039695"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2005.08.040","relation":{},"ISSN":["0015-0282"],"issn-type":[{"type":"print","value":"0015-0282"}],"subject":[],"published":{"date-parts":[[2006,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of gonadotropin-releasing hormone antagonists to overcome the drawbacks of intrauterine insemination on weekends","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2005.08.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}